The Australian share market is closed today for the Queen's birthday. In the spirit of this holiday, I thought I would look for 10 ASX 200 shares that I think are fit for a queen.
The 10 shares I have chosen are listed below. Here's why I think they should be in Buckingham Palace's portfolio:
a2 Milk Company Ltd (ASX: A2M)
The first ASX 200 share to consider buying is a2 Milk Company. It is a New Zealand-based infant formula and fresh milk company with a focus on A2-only products. This point of difference has gone down well with consumers. This is particularly the case in China where it sales continue to grow rapidly.
Afterpay Ltd (ASX: APT)
Another option to consider is Afterpay. I think this payments company could be a fantastic long term investment due to the way it is revolutionising the payments industry. It still has a significant runway for growth in the United States and opportunities to expand into mainland Europe and Asia.
Altium Limited (ASX: ALU)
Altium is an award-winning printed circuit board (PCB) design software provider. I think it is a standout buy due to its leading position in a market exposed to the Internet of Things boom. I expect the proliferation of electronic devices to lead to increasing demand for its software over the next decade.
Appen Ltd (ASX: APX)
Appen is another exciting ASX 200 share with enormous promise. Its million-plus team of crowd sourced experts prepare the data that goes into the artificial intelligence and machine learning models of some of the biggest tech companies in the world. Given how these markets are expected to grow materially in the future, Appen looks well-placed to profit.
Cochlear Limited (ASX: COH)
I think Cochlear would be another great option. It is one of the world's leading hearing solutions companies and has a long track record of delivering earnings growth. I believe this trend will continue for a long time to come thanks to the ageing populations tailwind.
CSL Limited (ASX: CSL)
Another ASX 200 share which I would buy is CSL. I think the biotherapeutics company's shares can continue to be market beaters over the next decade. This is due to the increasing demand for its immunoglobulins, its world class plasma collection network, growing demand for influenza vaccines, and its burgeoning research and development pipeline.
IDP Education Ltd (ASX: IEL)
I think it would be worth considering IDP Education. It is a provider of international student placement services and English language testing services. I've been very impressed at the way the company has been performing over the last few years and expect more of the same over the next decade.
Nanosonics Ltd (ASX: NAN)
Another ASX 200 share to consider buying is Nanosonics. I'm a big fan of the infection control specialist due to its very positive long term outlook. Its trophon EPR disinfection system for ultrasound probes has a massive market opportunity and could alone support solid earnings growth over the next decade. But the upcoming launch of new products make the investment proposition even more attractive.
REA Group Limited (ASX: REA)
REA Group is a digital advertising company that operates Australia's leading property websites. It also operates real estate websites in Europe, Asia, and the United States. While trading conditions are tough now, I expect these headwinds to ease once the pandemic passes. And when they do, I believe its earnings growth will accelerate once again.
SEEK Limited (ASX: SEK)
A final ASX 200 share to consider buying is SEEK. I'm very positive on its long term outlook due to the strength of its core ANZ business and the growth potential of its international operations. This is particularly the case with its China business. I believe it has the potential to underpin strong earnings growth over the next decade.
